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ABSTRACT: Chronic wounds are often recalcitrant to treatment because of high microbial bioburden and the problem of
microbial resistance. Silver is a broad-spectrum natural antimicrobial agent with wide applications extending to proprietary wound
dressings. Recently, silver nanoparticles have attracted attention in wound management. In the current study, the green synthesis of
nanoparticles was accomplished using a natural reducing agent, curcumin, which is a natural polyphenolic compound that is well-
known as a wound-healing agent. The hydrophobicity of curcumin was overcome by its microencapsulation in cyclodextrins. This
study demonstrates the production, characterization of silver nanoparticles using aqueous curcumin:hydroxypropyl-β-cyclodextrin
complex and loading them into bacterial cellulose hydrogel with moist wound-healing properties. These silver nanoparticle-loaded
bacterial cellulose hydrogels were characterized for wound-management applications. In addition to high cytocompatibility, these
novel dressings exhibited antimicrobial activity against three common wound-infecting pathogenic microbes Staphylococcus aureus,
Pseudomonas aeruginosa, and Candida auris.
■ INTRODUCTION
Microbial colonization, where it is not wanted, can led to
severe infections which can result in disability, disease, and
even death. Wound infections are one of the major factors
resulting in impaired healing.1−3 Wounds colonized by
opportunistic microbes may fail to follow the natural reparative
and regenerative stages involved in the healing process.4 In
addition, uncontrolled infections can prevent the restoration of
the anatomical and physiological integrity resulting in chronic
nonhealing wounds.5,6 To prevent infections, modern medi-
cine is dependent on antimicrobial agents such as antibiotics
which can either destroy pathogens or inhibit their growth.
Unfortunately, the misuse of antibiotics has resulted in the
emergence of a number of multiresistant microbes. Therefore,
antibiotic therapy often proves to be ineffective in eradicating
infections in chronic nonhealing wounds.3 Owing to the site
specific delivery, increased target site concentration, reduced
adverse effects, use of agents not suitable for oral and systemic
therapy and low incidence of resistance,7,8 antimicrobial-
loaded wound dressings have attracted wide interest as a
concurrent wound-management regime.
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Hydrogels are one of the promising candidates as wound
dressings because of their unprecedented properties including
their ability to maintain a moist microclimate at the wound site
which is proven to facilitate healing.9−11 A number of natural
and synthetic polymeric materials are in use to produce
hydrogel dressings.12,13 Bacterial cellulose (BC) is an example
of a natural biosynthetic cellulose hydrogel which has been
widely considered as a wound dressing because of its unique
properties.14−18 BC can be produced by several bacteria, but
Gluconacetobacter xylinus (G. xylinus) is considered as one of
the best for BC production.19 Our group has previously
reported the findings on the physicochemical characterization
and suitability of BC hydrogels as wound dressings.20 Although
BC does not have inherent antimicrobial activity, however, its
cross-linked fiber network structure encouraged several
research attempts of loading antimicrobials, anti-inflammatory,
antioxidants, and other healing agents for wound-dressing
applications.17,21,22 In continuation, in the presented study, an
investigation has been made to produce biosynthetic hydrogels
with healing properties for chronic wound management. Our
novel approach is consistent with the concept of the forensic
engineering of advanced polymeric materials (FEAPM) which
can help to understand the relationships between the structure
of the biomaterial used, its properties, and behavior for
practical applications.23
Currently the treatment of microbial infections is severely
affected by the emergence of new multiresistant microbes,
including bacteria and fungi. Gram-positive Staphylococcus
aureus has a great ability to develop multiple drug resistances.
Similarly, Gram-negative Pseudomonas aeruginosa, a common
opportunistic pathogen shows resistance to most penicillins,
cephalosporins, and carbapenems. Pathogenic fungi such as
Candida auris pose a significant health risk to patients suffering
from infected wounds and in particular to immunocompro-
mised individuals which can result in candidiasis/candidemia
and invasive aspergillosis. Recently, a new multidrug-resistant
strain of C. auris was discovered24 and has quickly become a
prolific nosocomial pathogen in the U.K.,25,26 with diagnoses
on all continents with 33 countries reporting incidents of
antifungal resistance. C. auris is resistant to most first- and
second-generation antifungals with 90% of isolates being
resistant to fluconazole, 40% resistant to amphotericin and 2%
to echinocandins such as caspofungin.27−29 The concern
regarding these pathogens centers around the increasing
resistance they are showing toward a very limited pool of
effective antimicrobials,30−32 and hence, the focus is on
targeted delivery by antimicrobial wound dressings.
Silver is a well-known antimicrobial effective against fungi,
yeast, and bacteria including several antibiotic-resistant
strains.33−35 The emergence of nanotechnology enabling the
production of silver nanoparticles has served a new therapeutic
modality. Because of their characteristic broad-spectrum
antimicrobial properties, silver nanoparticles (AgNP) have
received increased focus in biomedical applications including
for wound management.36−38 Among the several different
approaches to synthesize AgNP, the use of natural substances
like plant extracts has received wide research consideration
because of the safe and eco-friendly procedure.37,39−41
Curcumin (CUR), a natural polyphenol extracted from
turmeric, is a well-known wound-healing agent with proven
antimicrobial, antioxidant, and anti-inflammatory effects.22,42
In addition to its healing properties, CUR has been used as a
reducing and capping agent to produce AgNP.43 The main
challenge that limits the wider biomedical application of CUR
is its hydrophobic nature. Several chemical mediators like
dimethyl sulfoxide, dichloromethane, and sodium carbonate
are employed in AgNP synthesis from CUR.44−48 These
chemical mediators can have serious cytotoxic effects.48
Selection of solvent medium, reducing agent, and nontoxic
stabilizer are the main considerations in green nanoparticle
production.49,50 The current study reports the production of
AgNP following a green chemistry approach using an aqueous
solution of curcumin:hydroxypropyl-β-cyclodextrin
(CUR:HPβCD). These AgNP produced using CUR:HPβCD
(cAgNP) were characterized and loaded in the biosynthetic
BC hydrogels to produce hydrogel dressings. To the best of
our knowledge, the protocol presented herein to produce
cAgNP is novel, and this is the first time the production of
cAgNP-loaded BC has been reported. This report presents the
unique combination of silver nanoparticles with curcumin in
the biosynthetic BC to obtain the hydrogels for wound-
management applications. This study investigates the inherent
antimicrobial, antioxidant, and cytocompatibility properties of
these novel hydrogel dressings.
■ MATERIALS AND METHODS
Materials. Gluconoacetobacter xylinus (ATCC 23770), Pseudomo-
nas aeruginosa (NCIMB 8295), and Staphylococcus aureus (NCIMB
6571) were obtained from the University of Wolverhampton culture
collection. Candida auris (NCF 8971) was obtained from the Public
Health England Culture Collection, Porton Down, U.K. A stock
culture of P. aeruginosa and S. aureus were resuscitated at 37 °C on
tryptone soy agar (TSA) (Sigma-Aldrich, U.K.), G. xylinus at 30 °C
on mannitol agar, and C. auris at 37 °C on Sabouraud Dextrose Agar
(SDA). HS media was prepared following the standard protocol.51
Material for mannitol agar, SDA, and HS media were purchased from
Lab M (U.K.). Tryptone soya broth (TSB), disodium phosphate, and
citric acid were purchased from Sigma-Aldrich (U.K.). Overnight
broth cultures were prepared in appropriate medium using the stock
plates.
U251MG (U251), MSTO and Panc 1 cell lines were purchased
from ATCC (U.K.). Defibrinated horse whole blood was purchased
from TCS Biosciences Ltd.
Silver nitrate was purchased from Fischer Scientific (U.K.).
Hydroxypropyl-β-cyclodextrin (parenteral grade) was kindly provided
by Roquette (France). Curcumin and dimethyl sulfoxide (DMSO)
(spectrophotometric grade) were purchased from Alfa Aesar (U.K.).
Ringer tablets were purchased from Lab M (U.K.). Thiazolyl Blue
Tetrazolium Bromide (MTT), sodium bicarbonate, and 2,2-diphenyl-
1-picrylhydrazyl (DPPH) were purchased from Sigma-Aldrich (U.K.).
Sodium chloride 0.9% (w/v) (normal saline, intravenous infusion)
was purchased from Baxter, U.K. Sodium hydroxide was purchased
from Acros Organics (U.K.). NaCl (5.8 g/L) and glycine (7.6 g/L)
for preparing Sorensen’s glycine buffer were purchased from Sigma-
Aldrich, U.K. Trypsin was purchased from Lonza (Belgium).
Dulbecco’s Modified Eagle’s Medium (DMEM), fetal bovine serum
(FBS), L-glutamine, and antibiotic antimycotic were purchased from
Gibco (U.K.).
Preparation of CUR:HPβCD Inclusion Complex. Inclusion
complex was synthesized by the solvent evaporation method following
the protocol previously reported.22 Briefly, CUR solution (0.79 g in
37.5 mL acetone) was added dropwise to the aqueous HPβCD
solution (3.0 g in 12.5 mL deionized water) under constant stirring at
room temperature for slow and complete evaporation of acetone. The
sample was centrifuged, and the aqueous supernatant containing
CUR:HPβCD inclusion complex was frozen after filtration and
lyophilized.
Preparation and Characterization of cAgNP. Preparation of
cAgNP Using CUR:HPβCD. A novel green chemistry approach was
developed for cAgNP synthesis by reducing silver nitrate (AgNO3)
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with an aqueous solution of CUR:HPβCD. CUR:HPβCD (0.19 g)
solution was prepared by dissolving in deionized water (18 mL).
CUR:HPβCD aqueous solution was added dropwise with constant
stirring to 1 mM AgNO3 aqueous solution (42 mL) under the boiling
condition in conical flasks. The mixed solutions were boiled for 3 h
for reduction of Ag ions followed by cooling at room temperature for
30 min. The flask was covered with aluminum foil to maintain dark
conditions throughout the reduction process to avoid any photo-
chemical reactions.
Characterization of cAgNP. Dynamic Light Scattering (DLS)
and Zeta Potential. DLS measurements were performed on a
Malvern Zetasizer (nano ZS) at the University of Birmingham. Five
consecutive measurements were carried out at 25 °C with samples
equilibrated for 2 min before the measurements were started. The
results were averaged to calculate the mean size. The same instrument
was used to obtain the Zeta Potential values. The same samples were
used for size measurements and equilibrated for 2 min before
measurements were started. The results were obtained at 25 °C. Five
consecutive measurements were taken and averaged to calculate the
zeta potential.
Transmission Electron Microscopy (TEM). The shape, size, and
distribution of cAgNP produced using CUR:HPβCD were inves-
tigated by TEM. Briefly, a drop of aqueous colloidal cAgNP was
casted on a carbon-coated 300 mesh copper grid (agar scientific), left
for 30 min, rinsed off, and allowed to dry at room temperature in a
covered container. TEM imaging was performed using JEOL 1400
electron microscope, operated at 80 keV. Images were captured at
different range of magnifications. A 100 cAgNP were randomly
selected and measured using ImageJ to obtain the size distribution.
Preparation of cAgNP-Loaded BC Hydrogels. Production of
Bacterial Cellulose Hydrogels. Bacterial cellulose (BC) hydrogels
were prepared by the protocol reported previously.22 Briefly, G.
xylinus was selected for BC production, and hydrogels were
biosynthesized in sterilized Hestrin and Schramm (HS) culture
medium under static condition. BC pellicles were purified prior to
experimental use.
Loading cAgNP in BC Hydrogels. BC pellicles afterpurification
were padded dry on sterilized filter paper and aseptically loaded with
cAgNP by immersing in aqueous colloidal cAgNP overnight under
agitated conditions at 4 °C.
Characterization Studies. Morphological Study by Scanning
Electron Microscopy (SEM). Morphology of BC (neat) has been
previously reported.22,52 BC before purification, purified BC (neat)
and cAgNP-loaded BC hydrogels were cut in to discs (8 mm) using a
biopsy punch and lyophilized. These discs were then coated with
ultrafine gold coating using SC500 fine coater (Emscope, Kent, U.K.)
and placed on a carbon stub. The morphology of the samples was
studied using a Zeiss Evo 50 EP, SEM (Carl Zeiss AG, Oberkochen,
Germany).
Energy-Dispersive X-ray (EDX) Analysis. Lyophilized cAgNP-
loaded BC hydrogel samples were analyzed by EDX (Zeiss Evo 50 EP,
SEM) coupled with X-MaxN 50 Silicon Drift Detector (Oxford
Instruments), and the analysis was performed by Oxford Instruments
INCA Energy Dispersive Spectroscopy Nanoanalysis software using
the Point & ID function, to confirm the presence of silver.
Moisture Content (Mc). The wet mass (Ww) of BC (neat) and
cAgNP-loaded BC (test) hydrogels was recorded before lyophiliza-
tion, and the dry mass (Wd) was measured after 72 h of lyophilization.
Mc (%) was calculated using a formula:
M
W W
W
%
( )
100c
w d
w
= − ×
Cytocompatibility Study (In Vitro Cell Viability). Cytocompati-
bility of BC (neat) has been previously tested and reported using
conditioned media20 and BC discs22 on different mammalian cell
lines. To study the cytocompatibility of cAgNP-loaded BC, an in vitro
cell viability test was performed using Panc 1 (human pancreatic
ductal adenocarcinoma), U251 (human glioblastoma), and MSTO
(human mesothelioma) following the protocol previously reported.22
All cell lines were cultured in Dulbecco’s Modified Eagle’s Medium
(DMEM), supplemented with fetal bovine serum (FBS), antibiotic
antimycotic, and L-glutamine at 37 °C in humidity incubator with 5%
CO2. BC pellicles after pad drying were either rehydrated with PBS
(control) or cAgNP (test) overnight under agitated conditions (150
rpm) at 4 °C. These samples (control and test) were then aseptically
cut in discs (8 mm) using a biopsy punch for experimental purposes,
and the temperature was adjusted to 37 °C before use.
Briefly, 25 000 cells were seeded per well (24-well plate) for 24 h at
37 °C in 5% CO2 incubator. The cells were exposed to either free
cAgNP (equivalent amount) or cAgNP-loaded BC (8 mm discs) for
24 h to investigate the effect on cell viability. Cells without BC discs
and PBS-loaded BC discs (8 mm) were used as controls, respectively.
Cell viability was evaluated following the standard MTT assay
previously reported.22 Data recorded was analyzed statistically by two-
way analysis of variance (ANOVA) with a Tukey’s multicomparisons
test using GraphPad Prism.
Hemocompatibility. The hemocompatibility of cAgNP-loaded BC
hydrogels was tested following the protocol previously reported.22
Briefly, defibrinated horse whole blood was washed twice using
commercially available normal saline (pH 5.5), and blood cells were
resuspended in normal saline. cAgNP-loaded BC discs (8 mm) were
cut using a biopsy punch and incubated with 1.9 mL of horse blood
cells suspended in normal saline in test Eppendorf tubes. The positive
(+ve) control was blood cells suspended in distilled water and
negative (−ve) control was blood cells in normal saline. All the test
and control Eppendorf tubes were incubated at 4 °C for 2 h with
periodic inversion (every 15 min). Postincubation, after the removal
of BC discs from test Eppendorf tubes, all the tubes were centrifuged
at 3000 rpm for 10 min at 4 °C. The supernatant was decanted and
absorbance was recorded (540 nm) to calculate percentage hemolysis
(% Hemolysis).
%Hemolysis
(Abs of sample) (Abs of ve control)
(Abs of ve control) (Abs of ve control)
100
= − −
+ − −
×
Antimicrobial Study (Disc Diffusion Assay). The antimicrobial
activity of cAgNP-loaded BC was investigated against P. aeruginosa
(Gram−ve), S. aureus (Gram + ve) bacteria, and C. auris using the
disc diffusion assay. PBS-loaded BC and HPβCD-loaded BC were
used as controls. Discs (8 mm) of PBS-loaded BC, HPβCD-loaded
BC, and cAgNP-loaded BC were placed aseptically on TSA plates
spread with an overnight culture of P. aeruginosa or S. aureus, and
SDA plates were spread with an overnight culture of C. auris. Plates
were incubated at 37 °C for 24 h, and zones of inhibition (ZOI) were
measured. Data is presented as mean ± standard deviation (SD) and
analyzed statistically by two-way ANOVA with a Tukey’s multi
comparisons test using GraphPad Prism.
Antioxidant Study by DPPH Assay. The antioxidant potential of
cAgNP produced using CUR:HPβCD was evaluated using 2,2-
diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay. The
assay mixture with 1 mL of DPPH (80 μg/mL) methanolic solution
and 1 mL of test colloidal cAgNP (including the blank) after mixing
were incubated for 30 min in the dark at room temperature.
Absorbance was recorded (517 nm), and the free radical scavenging
potential was calculated as percent antioxidant effect (% E) as
E%
Abs Abs
Abs
100control sample
control
=
−
×
Transparency Test. Monitoring the healing process without the
need of removing dressing could help minimize trauma to the
granulating tissue. With the aim to use the hydrogel as a wound-
dressing application, the transparency level of cAgNP-loaded BC
hydrogels was assessed by simulation. PBS-loaded BC and cAgNP-
loaded-BC hydrogels were transferred on the laminated sheet of paper
with text typed in different colors. The clarity of text underneath the
hydrogel was examined to determine if the healing tissue at the wound
site could be observed through these hydrogels.
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■ RESULTS AND DISCUSSION
Preparation of cAgNP and cAgNP-Loaded BC Hydro-
gels. Most of the AgNP synthesis methods involve the use of
organic solvents and toxic reducing agents with the potential
threat to the environment and cytotoxic effect on mammalian
cell lines. The method reported herein involved bioreduction
of AgNO3 with an aqueous solution of CUR:HPβCD resulting
in nanoparticle formation. The color changed from colorless to
pale yellow at the start of CUR:HPβCD addition which
intensified with increased dosage and subsequently changed to
yellow-brown with time, suggesting the production of
nanoparticles. This could be due to the excitation of surface
plasmon vibrations in AgNPs, which is in accordance with
literature.40,53
G. xylinus produced BC hydrogel pellicles which were
harvested and purified. BC pellicles became clear after
purification. These results are in accordance with previous
reports.15,22,33,52,54 When the purified padded dry BC was
rehydrated with the aqueous colloidal cAgNP, the pellicles
reswelled and the color changed to yellow-brown. These
cAgNP-loaded BC hydrogels were stored at 4 °C throughout
the experimental procedure.
Characterization of cAgNP and cAgNP-Loaded BC
Hydrogels. The formation of colloidal cAgNP produced was
confirmed by testing its properties like size distribution and
charge. After loading aqueous colloidal cAgNP in the padded
dry BC, the physicochemical and in vitro hemocompatibility
and cytocompatibility hydrogels were investigated.
Particle Size Distribution and Surface Charge by
TEM, DLS, and Zeta Potential. The size and morphology of
cAgNP produced using CUR:HPβCD were studied from the
TEM images (Figure 1a−c). TEM imaging showed that the
morphology of the nanoparticles was mainly spherical in shape
with smooth edges. The majority of bioreduced cAgNP were in
the diameter range of 20−55 nm (80%) and the average size of
42.71 ± 17.97 nm. (Figure 1a−c). It emerged from the results
that nanoparticles were homogeneously surrounded by a thin
layer of capping material. As the method employed in the
current work involved only AgNO3 and CUR:HPβCD,
without the use of any organic solvents and additional capping
agents, this suggests that CUR:HPβCD was acting both as a
reducing and capping agent. These results are in agreement
with literature reporting the use of curcumin as a reducing and
capping agent.40,43,46,48,53
DLS measurements identified nanoparticles with the hydro-
dynamic diameter in the range of 182.10 ± 8.83 nm (Figure
1d) and the polydispersity index (PDI) value of 0.196 ± 0.009.
These results indicate both nucleation to form new nano-
particles and aggregation could be happening consecutively.
These findings are consistent with studies reported in the
literature.53,55 Low PDI indicates that the colloidal cAgNP was
not very polydispersed.
The zeta potential value is directly proportional to the
stability of nanoparticle dispersion.55 Zeta potential studies
revealed a negative charge on the synthesized nanoparticles
with the magnitude of −20.1 ± 0.702 mV. These findings are
in a close range to the previously reported values for AgNP
bioreduced using curcumin.43
Scanning Electron Microscopy (SEM). BC has a fine
fiber network structure with voids.21,22,52 SEM images revealed
G. xylinus trapped in the cellulose network before purification
(Figure 2a) and that bacteria were successfully removed on
Figure 1. Characterization of cAgNP produced using CUR:HPβCD. (a,b) TEM photomicrographs. (c) Size distribution as measured by TEM
analysis and calculated with 100 nanoparticles. (d) DLS data of cAgNP with size distribution.
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purification (Figure 2b). The interspersed voids in the
interwoven cellulose ribbons of BC allow impregnation of
healing agents.17,33,56 SEM of lyophilized cAgNP-loaded BC
revealed that cAgNP penetrated through the voids during
rehydration of padded dry BC pellicles and got physically
trapped in the fiber network structure (Figure 2c). Also, it
emerged that along with bioreduced cAgNP, there was free
CUR:HPβCD trapped in the BC. In addition to the reducing
Figure 2. SEM photomicrographs of (a) unwashed BC, entangled G. xylinus highlighted. (b) BC after purification. (c,d) cAgNP loaded in BC fiber
network.
Figure 3. EDX spectrum of cAgNP-loaded BC.
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and capping properties in cAgNP synthesis, CUR:HPβCD has
been demonstrated to have wound-healing properties.22 The
excess of CUR inclusion complex in cAgNP-loaded BC may
deliver additional benefits contributing to wound healing.
Morphology and size of nanoparticles was also determined
in the SEM photomicrographs (Figure 2d). The average
diameter was in the range of 37.2−65.1 nm, and most of the
nanoparticles appeared spherical. These results are in
accordance with TEM results discussed in the section above.
Energy-Dispersive X-ray (EDX) Analysis. The elemental
analysis was carried out by EDX studies. The results confirmed
that BC (neat) is composed mainly of carbon and oxygen
which is in accordance with our previously reported data.33 In
addition to carbon and oxygen, detection of silver in the EDX
spectra of cAgNP-loaded BC (test) confirmed nanoparticle
loading in the test samples (Figure 3).
Moisture Content (Mc). BC hydrogels have been reported
to have a unique property of resistance to degradation despite
considerable moisture content which is several times its dry
mass.14 This strength is contributed by its cross-linked fiber
network structure. In the current study, the moisture content
of neat BC and cAgNP-loaded BC hydrogels was evaluated.
The results confirmed that neat BC pellicles imbibed 99.68 ±
0.09% (v/w) (n = 3) water, which is in accordance with
previously reported data (>99.5%) for neat BC hydrogels.20,22
Moreover, the study on cAgNP-loaded BC revealed that the
moisture content in these hydrogels was 98.86 ± 0.04% (n =
3). These findings indicate that the difference in the mass of
neat BC and cAgNP-loaded BC is contributed by cAgNP and
CUR:HPβCD that gets physically trapped in the fiber network
of BC during the loading process.
The high moisture content in BC can confer many benefits
such as increased malleability, soft texture, and creating a moist
environment with increased dissolved oxygen to facilitate
aerobic conditions at the wound-dressing interface. In addition,
these hydrogels may ease removal of the dressing, reduce pain
sensation and therefore improve patient comfort. These
features have been reported to facilitate the wound-healing
process,15,21,57,58 and therefore, BC has attracted increased
interest in the wound-care sector.
Cytocompatibility (In Vitro Study). The cytocompatible
nature of BC is well documented in the literature.20−22,59 It is
one of the many intrinsic features that has resulted in BC-
based proprietary products like Dermafill, Biofill, XCell, and
Gengiflex.57,60−62 In this study, the cytocompatibility of
cAgNP-loaded BC hydrogels was evaluated using three
different mammalian cell lines. The cytotoxicity as determined
by MTT assay revealed that cAgNP-loaded BC is cytocompat-
ible as all the tested cell lines demonstrated good survival rate
(Figure 4a).
Furthermore, we compared the cytocompatibility of free
cAgNP to cAgNP-loaded BC on U251, MSTO and Panc 1 cell
lines. The results demonstrated that free cAgNP had a
cytotoxic effect on all the tested cell lines, resulting in lower
cell viability compared with cAgNP-loaded in BC (p < 0.001)
(Figure 4a,b). These results suggest that BC controls the
release of cAgNP thus minimizing the cytotoxic effect on the
mammalian cells. These findings support the potential
Figure 4. Cytocompatibility test results. (a) Bar graph showing the cell viability (%) after 24 h exposure to cAgNP-loaded BC and free cAgNP
(equivalent amount) (n = 8). Representative photomicrographs of cells (10× magnification) after exposure to cAgNP-loaded BC and free cAgNP
for 24 h.
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application of cAgNP-loaded BC for wound management as
hydrogel dressings.
Hemocompatibility. Hemocompatibility is an important
property for biomedical applications of a material. BC has been
reported to be hemocompatible; hence, it has been used in
proprietary wound dressings.20,63,64 In the current study,
cAgNPs were prepared in deionized water; hence, the
hypothesis was drawn that cAgNP-loaded BC hydrogels may
have hemolytic properties. The test results revealed that
cAgNP-loaded BC hydrogels have a percentage hemolysis of
6.85 ± 1.12% (n = 6). According to the ASTM F756 standards
hemolytic indices, this range is over the threshold value of 5%
hence cAgNP-loaded BC hydrogels would be classified as a
hemolytic material.65 The higher hemolysis (%) of the tested
hydrogels could be attributed to the use of deionized water
instead of the isotonic solution for the synthesis of cAgNP.
In the case of a chronic wound, there could be necrotic
tissue or slough at the wound bed, and hence, the hemolytic
behavior of these hydrogels may be minimal. Further research
on the production of AgNP using CUR:HPβCD dissolved in
isotonic solution may improve hemocompatibility of these
hydrogels.
Antimicrobial Study. Invasion of opportunistic microbes
could impair wound healing, leading to chronic nonhealing
wounds.6,66 Silver nanoparticles have been intensively studied
as antimicrobial agents.40,49,53 Different mechanisms of action
of AgNPs have been proposed as their antibacterial and
antifungal effect is not completely known.67 In bacteria, AgNPs
have the ability to increase the permeability of the cell
membrane, interfere with DNA replication, denature bacterial
proteins, and release silver ions inside the bacterial cell.49,67
The antifungal action of silver nanoparticles are thought to
increase the reactive oxygen species within the fungal cell and
increase membrane permeability resulting in cell death.68
In the current study, PBS-loaded BC, HPβCD-loaded BC,
and cAgNP-loaded BC hydrogels were tested against P.
aeruginosa, S. aureus, and C. auris using the disc diffusion
assay at 24 h. PBS-loaded BC and HPβCD-loaded BC did not
exhibit antimicrobial activity; however, cAgNP-loaded BC
demonstrated significant antimicrobial activity (p < 0.001)
against all three of the tested microbial strains (Figure 5).
These results confirm the broad spectrum antimicrobial
activity of cAgNP-loaded in BC. Moreover, it is apparent that
cAgNP-loaded in BC has stronger antimicrobial activity
(Figure 5) against P. aeruginosa as compared with S. aureus
(p < 0.001). This could be explained by the difference in the
cell structure of Gram-positive and Gram-negative bacteria.
AgNPs have been reported to have the ability to separate
cytoplasm from the bacterial cell wall (plasmolysis effect)
leading to cell death in P. aeruginosa. In S. aureus, AgNPs act
differently and cause the bacterial cell death by inhibiting the
cell wall synthesis.49,67,69
Antioxidant Activity of cAgNP by DPPH Assay.
Oxidative stress at the wound site may interfere with the
healing process;70 hence, a wound dressing with antioxidant
properties along with antimicrobial activity may prove to be
beneficial.71 CUR has been reported to have healing properties
including antimicrobial and antioxidant activities. It has been
previously demonstrated that these properties were preserved
in the inclusion complex of CUR in HPβCD.22
In the current study, cAgNP were successfully prepared
using CUR:HPβCD as reducing and stabilizing agent. The
percent antioxidant effect (% E) for aqueous cAgNP colloidal
suspension against DPPH was determined to be 76.65 ±
3.21% (n = 6). The test results confirmed that silver nitrate and
HPβCD does not have antioxidant activity, which is in
accordance with previously reported findings.22 These results
confirmed that colloidal cAgNP aqueous medium produced
using CUR:HPβCD has antioxidant activity, and when it is
loaded in BC to produce hydrogels, it could prove to be
beneficial in wound-healing process.
Transparency Test. Monitoring of wound-healing process
is vital from a clinical perspective.72−74 Routinely, this involves
the removal of a dressing which can disturb the granulating
tissue and could cause trauma to the wound. A dressing with
the feature enabling noninvasive monitoring could be
beneficial in wound healing.
The transparent nature of BC has already been reported,22
and in this study, PBS-loaded BC hydrogels reconfirmed these
findings (Figure 6a). In this study, the transparency property of
cAgNP-loaded BC was evaluated by reading the text in
different colors on white laminated paper sheet through the
test hydrogels. The results (Figure 6b) demonstrate cAgNP-
loaded BC hydrogels allow monitoring the wound without the
need for removal of the dressing. This transparency testing is a
simulation study, and in order to confirm the results, clinical
validation would be required and could be evaluated using in
vivo animal models.
■ CONCLUSIONS
The development of advanced polymeric materials requires
precise evaluation of structure, properties, and behavior to
avoid potential failures of the commercial products manufac-
tured from them. The current study demonstrates the
Figure 5. Antimicrobial disc diffusion assay results for PBS-loaded
BC, HPβCD-loaded BC, and cAgNP-loaded BC against P. aeruginosa,
S. aureus, and C. auris at 24 h (n = 10; error bars = SD).
Figure 6. Photomicrographs with the visual appearance of (a) BC
loaded with PBS (b) cAgNP-loaded BC hydrogel pellicle.
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production and both physicochemical and in vitro character-
ization of cAgNP-loaded BC hydrogels. It also increases
efficiency and minimizes the potential failure of precisely
structured biomaterials before, during, and after specific
applications. The results confirmed that cAgNPs were
successfully synthesized, following the green chemistry
approach using CUR:HPβCD and loaded in BC to produce
hydrogels with a potential wound-dressing application. These
hydrogels demonstrated broad-spectrum antimicrobial activity
along with antioxidant properties. Moreover, the hydrogels
showed cytocompatibility with the tested cell lines. The high
moisture content and the good level of transparency further
advocate their potential application in the management of
chronic wounds with high microbial bioburden.
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